Mineralys Therapeutics, Inc. Liquidation Value
MLYS
Other
Cash & Equivalents
$172.92M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $172.92M
Total Obligations: -$15.11M
$157.81M
Per share: $1.94
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $172.92M
AR: $0
Total Obligations: -$15.11M
$157.81M
Per share: $1.94
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $172.92M
AR: $0
Inventory: $0
Total Obligations: -$15.11M
$157.81M
Per share: $1.94
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $157.81M | $1.94 |
| Liquid Liquidation Value | $157.81M | $1.94 |
| Operating Liquidation Value | $157.81M | $1.94 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $172.92M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $15.11M |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 81.5M |
Explore all 117 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $172.92M | N/A | N/A | $2.02M | $15.11M | N/A | N/A | N/A |
| 2025-09-30 | $217.60M | N/A | N/A | $1.12M | $23.52M | N/A | N/A | N/A |
| 2025-06-30 | $101.79M | N/A | N/A | $3.16M | $22.17M | N/A | N/A | N/A |
| 2025-03-31 | $165.01M | N/A | N/A | $373,000 | $13.39M | N/A | N/A | N/A |
| 2024-12-31 | $114.09M | N/A | N/A | $479,000 | $14.65M | N/A | N/A | N/A |
| 2024-09-30 | $97.27M | N/A | N/A | $3.11M | $31.32M | N/A | N/A | N/A |
| 2024-06-30 | $67.86M | N/A | N/A | $1.71M | $28.40M | N/A | N/A | N/A |
| 2024-03-31 | $90.42M | N/A | N/A | $4.26M | $19.20M | N/A | N/A | N/A |
▼ Community Notes